ペット用寄生虫予防＆制御薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Pet Parasite Prevention and Control Drugs Market Insights, Forecast to 2028

• レポートコード：QY2207E10462 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のペット用寄生虫予防＆制御薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にペット用寄生虫予防＆制御薬の世界市場のxxx％を占める「局所薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「犬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のペット用寄生虫予防＆制御薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのペット用寄生虫予防＆制御薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのペット用寄生虫予防＆制御薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ペット用寄生虫予防＆制御薬のグローバル主要メーカーには、Boehringer Ingelheim、Bayer、Zoetis、Dechra Pharmaceuticals、Chanelle Pharma、Merck Animal Health、Elanco、Virbac、Vetoquinolなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ペット用寄生虫予防＆制御薬市場は、種類と用途によって区分されます。世界のペット用寄生虫予防＆制御薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 局所薬、注射薬、経口薬 【用途別セグメント】 犬、猫、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ペット用寄生虫予防＆制御薬製品概要 - 種類別市場（局所薬、注射薬、経口薬） - 用途別市場（犬、猫、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のペット用寄生虫予防＆制御薬販売量予測2017-2028 - 世界のペット用寄生虫予防＆制御薬売上予測2017-2028 - ペット用寄生虫予防＆制御薬の地域別販売量 - ペット用寄生虫予防＆制御薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ペット用寄生虫予防＆制御薬販売量 - 主要メーカー別ペット用寄生虫予防＆制御薬売上 - 主要メーカー別ペット用寄生虫予防＆制御薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（局所薬、注射薬、経口薬） - ペット用寄生虫予防＆制御薬の種類別販売量 - ペット用寄生虫予防＆制御薬の種類別売上 - ペット用寄生虫予防＆制御薬の種類別価格 ・用途別市場規模（犬、猫、その他） - ペット用寄生虫予防＆制御薬の用途別販売量 - ペット用寄生虫予防＆制御薬の用途別売上 - ペット用寄生虫予防＆制御薬の用途別価格 ・北米市場 - 北米のペット用寄生虫予防＆制御薬市場規模（種類別、用途別） - 主要国別のペット用寄生虫予防＆制御薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのペット用寄生虫予防＆制御薬市場規模（種類別、用途別） - 主要国別のペット用寄生虫予防＆制御薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のペット用寄生虫予防＆制御薬市場規模（種類別、用途別） - 主要国別のペット用寄生虫予防＆制御薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のペット用寄生虫予防＆制御薬市場規模（種類別、用途別） - 主要国別のペット用寄生虫予防＆制御薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのペット用寄生虫予防＆制御薬市場規模（種類別、用途別） - 主要国別のペット用寄生虫予防＆制御薬市場規模（トルコ、サウジアラビア） ・企業情報 Boehringer Ingelheim、Bayer、Zoetis、Dechra Pharmaceuticals、Chanelle Pharma、Merck Animal Health、Elanco、Virbac、Vetoquinol ・産業チェーン及び販売チャネル分析 - ペット用寄生虫予防＆制御薬の産業チェーン分析 - ペット用寄生虫予防＆制御薬の原材料 - ペット用寄生虫予防＆制御薬の生産プロセス - ペット用寄生虫予防＆制御薬の販売及びマーケティング - ペット用寄生虫予防＆制御薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ペット用寄生虫予防＆制御薬の産業動向 - ペット用寄生虫予防＆制御薬のマーケットドライバー - ペット用寄生虫予防＆制御薬の課題 - ペット用寄生虫予防＆制御薬の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Pet Parasite Prevention and Control Drugs Market
Due to the COVID-19 pandemic, the global Pet Parasite Prevention and Control Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Topical Medication accounting for % of the Pet Parasite Prevention and Control Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Dog segment is altered to an % CAGR throughout this forecast period.
China Pet Parasite Prevention and Control Drugs market size is valued at US$ million in 2021, while the US and Europe Pet Parasite Prevention and Control Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pet Parasite Prevention and Control Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Pet Parasite Prevention and Control Drugs include Boehringer Ingelheim, Bayer, Zoetis, Dechra Pharmaceuticals, Chanelle Pharma, Merck Animal Health, Elanco, Virbac and Vetoquinol. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Pet Parasite Prevention and Control Drugs Scope and Segment
Pet Parasite Prevention and Control Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pet Parasite Prevention and Control Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Topical Medication
Injection Medication
Oral Medication
Segment by Application
Dog
Cat
Others
By Company
Boehringer Ingelheim
Bayer
Zoetis
Dechra Pharmaceuticals
Chanelle Pharma
Merck Animal Health
Elanco
Virbac
Vetoquinol
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Pet Parasite Prevention and Control Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Topical Medication
1.2.3 Injection Medication
1.2.4 Oral Medication
1.3 Market by Application
1.3.1 Global Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pet Parasite Prevention and Control Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Pet Parasite Prevention and Control Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Pet Parasite Prevention and Control Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pet Parasite Prevention and Control Drugs Sales by Region
2.4.1 Global Pet Parasite Prevention and Control Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Pet Parasite Prevention and Control Drugs by Region (2023-2028)
2.5 Global Pet Parasite Prevention and Control Drugs Revenue by Region
2.5.1 Global Pet Parasite Prevention and Control Drugs Revenue by Region (2017-2022)
2.5.2 Global Pet Parasite Prevention and Control Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pet Parasite Prevention and Control Drugs Sales by Manufacturers
3.1.1 Global Top Pet Parasite Prevention and Control Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Pet Parasite Prevention and Control Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pet Parasite Prevention and Control Drugs in 2021
3.2 Global Pet Parasite Prevention and Control Drugs Revenue by Manufacturers
3.2.1 Global Pet Parasite Prevention and Control Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pet Parasite Prevention and Control Drugs Revenue in 2021
3.3 Global Pet Parasite Prevention and Control Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pet Parasite Prevention and Control Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pet Parasite Prevention and Control Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pet Parasite Prevention and Control Drugs Sales by Type
4.1.1 Global Pet Parasite Prevention and Control Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Pet Parasite Prevention and Control Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Pet Parasite Prevention and Control Drugs Sales Market Share by Type (2017-2028)
4.2 Global Pet Parasite Prevention and Control Drugs Revenue by Type
4.2.1 Global Pet Parasite Prevention and Control Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Pet Parasite Prevention and Control Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Pet Parasite Prevention and Control Drugs Price by Type
4.3.1 Global Pet Parasite Prevention and Control Drugs Price by Type (2017-2022)
4.3.2 Global Pet Parasite Prevention and Control Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pet Parasite Prevention and Control Drugs Sales by Application
5.1.1 Global Pet Parasite Prevention and Control Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Pet Parasite Prevention and Control Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Pet Parasite Prevention and Control Drugs Sales Market Share by Application (2017-2028)
5.2 Global Pet Parasite Prevention and Control Drugs Revenue by Application
5.2.1 Global Pet Parasite Prevention and Control Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Pet Parasite Prevention and Control Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Pet Parasite Prevention and Control Drugs Price by Application
5.3.1 Global Pet Parasite Prevention and Control Drugs Price by Application (2017-2022)
5.3.2 Global Pet Parasite Prevention and Control Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pet Parasite Prevention and Control Drugs Market Size by Type
6.1.1 North America Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
6.1.2 North America Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
6.2 North America Pet Parasite Prevention and Control Drugs Market Size by Application
6.2.1 North America Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
6.2.2 North America Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
6.3 North America Pet Parasite Prevention and Control Drugs Market Size by Country
6.3.1 North America Pet Parasite Prevention and Control Drugs Sales by Country (2017-2028)
6.3.2 North America Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Pet Parasite Prevention and Control Drugs Market Size by Type
7.1.1 Europe Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
7.1.2 Europe Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
7.2 Europe Pet Parasite Prevention and Control Drugs Market Size by Application
7.2.1 Europe Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
7.2.2 Europe Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
7.3 Europe Pet Parasite Prevention and Control Drugs Market Size by Country
7.3.1 Europe Pet Parasite Prevention and Control Drugs Sales by Country (2017-2028)
7.3.2 Europe Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pet Parasite Prevention and Control Drugs Market Size by Type
8.1.1 Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Pet Parasite Prevention and Control Drugs Market Size by Application
8.2.1 Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Pet Parasite Prevention and Control Drugs Market Size by Region
8.3.1 Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pet Parasite Prevention and Control Drugs Market Size by Type
9.1.1 Latin America Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
9.1.2 Latin America Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
9.2 Latin America Pet Parasite Prevention and Control Drugs Market Size by Application
9.2.1 Latin America Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
9.2.2 Latin America Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
9.3 Latin America Pet Parasite Prevention and Control Drugs Market Size by Country
9.3.1 Latin America Pet Parasite Prevention and Control Drugs Sales by Country (2017-2028)
9.3.2 Latin America Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pet Parasite Prevention and Control Drugs Market Size by Type
10.1.1 Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Pet Parasite Prevention and Control Drugs Market Size by Application
10.2.1 Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Pet Parasite Prevention and Control Drugs Market Size by Country
10.3.1 Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Overview
11.1.3 Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Zoetis
11.3.1 Zoetis Corporation Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Zoetis Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Dechra Pharmaceuticals
11.4.1 Dechra Pharmaceuticals Corporation Information
11.4.2 Dechra Pharmaceuticals Overview
11.4.3 Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dechra Pharmaceuticals Recent Developments
11.5 Chanelle Pharma
11.5.1 Chanelle Pharma Corporation Information
11.5.2 Chanelle Pharma Overview
11.5.3 Chanelle Pharma Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Chanelle Pharma Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chanelle Pharma Recent Developments
11.6 Merck Animal Health
11.6.1 Merck Animal Health Corporation Information
11.6.2 Merck Animal Health Overview
11.6.3 Merck Animal Health Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Merck Animal Health Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Animal Health Recent Developments
11.7 Elanco
11.7.1 Elanco Corporation Information
11.7.2 Elanco Overview
11.7.3 Elanco Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Elanco Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Elanco Recent Developments
11.8 Virbac
11.8.1 Virbac Corporation Information
11.8.2 Virbac Overview
11.8.3 Virbac Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Virbac Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Virbac Recent Developments
11.9 Vetoquinol
11.9.1 Vetoquinol Corporation Information
11.9.2 Vetoquinol Overview
11.9.3 Vetoquinol Pet Parasite Prevention and Control Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Vetoquinol Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Vetoquinol Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pet Parasite Prevention and Control Drugs Industry Chain Analysis
12.2 Pet Parasite Prevention and Control Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pet Parasite Prevention and Control Drugs Production Mode & Process
12.4 Pet Parasite Prevention and Control Drugs Sales and Marketing
12.4.1 Pet Parasite Prevention and Control Drugs Sales Channels
12.4.2 Pet Parasite Prevention and Control Drugs Distributors
12.5 Pet Parasite Prevention and Control Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pet Parasite Prevention and Control Drugs Industry Trends
13.2 Pet Parasite Prevention and Control Drugs Market Drivers
13.3 Pet Parasite Prevention and Control Drugs Market Challenges
13.4 Pet Parasite Prevention and Control Drugs Market Restraints
14 Key Findings in The Global Pet Parasite Prevention and Control Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Topical Medication
Table 3. Major Manufacturers of Injection Medication
Table 4. Major Manufacturers of Oral Medication
Table 5. Global Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Pet Parasite Prevention and Control Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Pet Parasite Prevention and Control Drugs Sales by Region (2017-2022) & (K Units)
Table 8. Global Pet Parasite Prevention and Control Drugs Sales Market Share by Region (2017-2022)
Table 9. Global Pet Parasite Prevention and Control Drugs Sales by Region (2023-2028) & (K Units)
Table 10. Global Pet Parasite Prevention and Control Drugs Sales Market Share by Region (2023-2028)
Table 11. Global Pet Parasite Prevention and Control Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Region (2017-2022)
Table 13. Global Pet Parasite Prevention and Control Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Region (2023-2028)
Table 15. Global Pet Parasite Prevention and Control Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Pet Parasite Prevention and Control Drugs Sales Share by Manufacturers (2017-2022)
Table 17. Global Pet Parasite Prevention and Control Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Pet Parasite Prevention and Control Drugs Revenue Share by Manufacturers (2017-2022)
Table 19. Pet Parasite Prevention and Control Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Pet Parasite Prevention and Control Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Pet Parasite Prevention and Control Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Parasite Prevention and Control Drugs as of 2021)
Table 22. Pet Parasite Prevention and Control Drugs Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Pet Parasite Prevention and Control Drugs Product Offered
Table 24. Date of Manufacturers Enter into Pet Parasite Prevention and Control Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pet Parasite Prevention and Control Drugs Sales by Type (2017-2022) & (K Units)
Table 27. Global Pet Parasite Prevention and Control Drugs Sales by Type (2023-2028) & (K Units)
Table 28. Global Pet Parasite Prevention and Control Drugs Sales Share by Type (2017-2022)
Table 29. Global Pet Parasite Prevention and Control Drugs Sales Share by Type (2023-2028)
Table 30. Global Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Pet Parasite Prevention and Control Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Pet Parasite Prevention and Control Drugs Revenue Share by Type (2017-2022)
Table 33. Global Pet Parasite Prevention and Control Drugs Revenue Share by Type (2023-2028)
Table 34. Pet Parasite Prevention and Control Drugs Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Pet Parasite Prevention and Control Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Pet Parasite Prevention and Control Drugs Sales by Application (2017-2022) & (K Units)
Table 37. Global Pet Parasite Prevention and Control Drugs Sales by Application (2023-2028) & (K Units)
Table 38. Global Pet Parasite Prevention and Control Drugs Sales Share by Application (2017-2022)
Table 39. Global Pet Parasite Prevention and Control Drugs Sales Share by Application (2023-2028)
Table 40. Global Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Pet Parasite Prevention and Control Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Pet Parasite Prevention and Control Drugs Revenue Share by Application (2017-2022)
Table 43. Global Pet Parasite Prevention and Control Drugs Revenue Share by Application (2023-2028)
Table 44. Pet Parasite Prevention and Control Drugs Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Pet Parasite Prevention and Control Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Pet Parasite Prevention and Control Drugs Sales by Type (2017-2022) & (K Units)
Table 47. North America Pet Parasite Prevention and Control Drugs Sales by Type (2023-2028) & (K Units)
Table 48. North America Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Pet Parasite Prevention and Control Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Pet Parasite Prevention and Control Drugs Sales by Application (2017-2022) & (K Units)
Table 51. North America Pet Parasite Prevention and Control Drugs Sales by Application (2023-2028) & (K Units)
Table 52. North America Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Pet Parasite Prevention and Control Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Pet Parasite Prevention and Control Drugs Sales by Country (2017-2022) & (K Units)
Table 55. North America Pet Parasite Prevention and Control Drugs Sales by Country (2023-2028) & (K Units)
Table 56. North America Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Pet Parasite Prevention and Control Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Pet Parasite Prevention and Control Drugs Sales by Type (2017-2022) & (K Units)
Table 59. Europe Pet Parasite Prevention and Control Drugs Sales by Type (2023-2028) & (K Units)
Table 60. Europe Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Pet Parasite Prevention and Control Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Pet Parasite Prevention and Control Drugs Sales by Application (2017-2022) & (K Units)
Table 63. Europe Pet Parasite Prevention and Control Drugs Sales by Application (2023-2028) & (K Units)
Table 64. Europe Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Pet Parasite Prevention and Control Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Pet Parasite Prevention and Control Drugs Sales by Country (2017-2022) & (K Units)
Table 67. Europe Pet Parasite Prevention and Control Drugs Sales by Country (2023-2028) & (K Units)
Table 68. Europe Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Pet Parasite Prevention and Control Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Pet Parasite Prevention and Control Drugs Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Pet Parasite Prevention and Control Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Pet Parasite Prevention and Control Drugs Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Pet Parasite Prevention and Control Drugs Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Pet Parasite Prevention and Control Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Pet Parasite Prevention and Control Drugs Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Pet Parasite Prevention and Control Drugs Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Pet Parasite Prevention and Control Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Pet Parasite Prevention and Control Drugs Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Pet Parasite Prevention and Control Drugs Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Pet Parasite Prevention and Control Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Pet Parasite Prevention and Control Drugs Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 106. Boehringer Ingelheim Corporation Information
Table 107. Boehringer Ingelheim Description and Major Businesses
Table 108. Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Boehringer Ingelheim Recent Developments
Table 111. Bayer Corporation Information
Table 112. Bayer Description and Major Businesses
Table 113. Bayer Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. Bayer Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Bayer Recent Developments
Table 116. Zoetis Corporation Information
Table 117. Zoetis Description and Major Businesses
Table 118. Zoetis Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Zoetis Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Zoetis Recent Developments
Table 121. Dechra Pharmaceuticals Corporation Information
Table 122. Dechra Pharmaceuticals Description and Major Businesses
Table 123. Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Dechra Pharmaceuticals Recent Developments
Table 126. Chanelle Pharma Corporation Information
Table 127. Chanelle Pharma Description and Major Businesses
Table 128. Chanelle Pharma Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. Chanelle Pharma Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Chanelle Pharma Recent Developments
Table 131. Merck Animal Health Corporation Information
Table 132. Merck Animal Health Description and Major Businesses
Table 133. Merck Animal Health Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Merck Animal Health Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Merck Animal Health Recent Developments
Table 136. Elanco Corporation Information
Table 137. Elanco Description and Major Businesses
Table 138. Elanco Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Elanco Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Elanco Recent Developments
Table 141. Virbac Corporation Information
Table 142. Virbac Description and Major Businesses
Table 143. Virbac Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Virbac Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Virbac Recent Developments
Table 146. Vetoquinol Corporation Information
Table 147. Vetoquinol Description and Major Businesses
Table 148. Vetoquinol Pet Parasite Prevention and Control Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Vetoquinol Pet Parasite Prevention and Control Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Vetoquinol Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Pet Parasite Prevention and Control Drugs Distributors List
Table 154. Pet Parasite Prevention and Control Drugs Customers List
Table 155. Pet Parasite Prevention and Control Drugs Market Trends
Table 156. Pet Parasite Prevention and Control Drugs Market Drivers
Table 157. Pet Parasite Prevention and Control Drugs Market Challenges
Table 158. Pet Parasite Prevention and Control Drugs Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Pet Parasite Prevention and Control Drugs Product Picture
Figure 3. Global Pet Parasite Prevention and Control Drugs Market Share by Type in 2021 & 2028
Figure 3. Topical Medication Product Picture
Figure 4. Injection Medication Product Picture
Figure 5. Oral Medication Product Picture
Figure 6. Global Pet Parasite Prevention and Control Drugs Market Share by Application in 2021 & 2028
Figure 7. Dog
Figure 8. Cat
Figure 9. Others
Figure 10. Pet Parasite Prevention and Control Drugs Report Years Considered
Figure 11. Global Pet Parasite Prevention and Control Drugs Sales 2017-2028 (K Units)
Figure 12. Global Pet Parasite Prevention and Control Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Pet Parasite Prevention and Control Drugs Revenue 2017-2028 (US$ Million)
Figure 14. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Pet Parasite Prevention and Control Drugs Sales Market Share by Region (2017-2022)
Figure 16. Global Pet Parasite Prevention and Control Drugs Sales Market Share by Region (2023-2028)
Figure 17. North America Pet Parasite Prevention and Control Drugs Sales YoY (2017-2028) & (K Units)
Figure 18. North America Pet Parasite Prevention and Control Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Pet Parasite Prevention and Control Drugs Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Pet Parasite Prevention and Control Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Pet Parasite Prevention and Control Drugs Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Pet Parasite Prevention and Control Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Pet Parasite Prevention and Control Drugs Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Pet Parasite Prevention and Control Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Pet Parasite Prevention and Control Drugs Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Pet Parasite Prevention and Control Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Pet Parasite Prevention and Control Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Pet Parasite Prevention and Control Drugs in the World: Market Share by Pet Parasite Prevention and Control Drugs Revenue in 2021
Figure 29. Global Pet Parasite Prevention and Control Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Pet Parasite Prevention and Control Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Pet Parasite Prevention and Control Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2017-2028)
Figure 34. North America Pet Parasite Prevention and Control Drugs Sales Market Share by Type (2017-2028)
Figure 35. North America Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2017-2028)
Figure 36. North America Pet Parasite Prevention and Control Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2017-2028)
Figure 38. North America Pet Parasite Prevention and Control Drugs Sales Share by Country (2017-2028)
Figure 39. North America Pet Parasite Prevention and Control Drugs Revenue Share by Country (2017-2028)
Figure 40. United States Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Pet Parasite Prevention and Control Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2017-2028)
Figure 44. Europe Pet Parasite Prevention and Control Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2017-2028)
Figure 46. Europe Pet Parasite Prevention and Control Drugs Sales Share by Country (2017-2028)
Figure 47. Europe Pet Parasite Prevention and Control Drugs Revenue Share by Country (2017-2028)
Figure 48. Germany Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. France Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Pet Parasite Prevention and Control Drugs Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Pet Parasite Prevention and Control Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Pet Parasite Prevention and Control Drugs Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Pet Parasite Prevention and Control Drugs Revenue Share by Region (2017-2028)
Figure 59. China Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. India Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Pet Parasite Prevention and Control Drugs Sales Market Share by Type (2017-2028)
Figure 69. Latin America Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Pet Parasite Prevention and Control Drugs Sales Market Share by Application (2017-2028)
Figure 71. Latin America Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Pet Parasite Prevention and Control Drugs Sales Share by Country (2017-2028)
Figure 73. Latin America Pet Parasite Prevention and Control Drugs Revenue Share by Country (2017-2028)
Figure 74. Mexico Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Pet Parasite Prevention and Control Drugs Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Pet Parasite Prevention and Control Drugs Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Pet Parasite Prevention and Control Drugs Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Pet Parasite Prevention and Control Drugs Revenue Share by Country (2017-2028)
Figure 83. Turkey Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Pet Parasite Prevention and Control Drugs Revenue (2017-2028) & (US$ Million)
Figure 86. Pet Parasite Prevention and Control Drugs Value Chain
Figure 87. Pet Parasite Prevention and Control Drugs Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---